BlackRock »

Carmell Therapeutics Corp - US shares owned by BlackRock

Quarter-by-quarter ownership of Carmell Therapeutics Corp - US (CTCX) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Carmell Therapeutics Corp - US

Tip: Access up to 7 years of quarterly data

All positions including Carmell Therapeutics Corp - US held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Carmell Therapeutics Corp - US by BlackRock

Quarter filed Position value Share count Share price at filing
2024-06-30 $48k 36k 1.33
2024-03-31 $81k 32k 2.56
2023-09-30 $114k 32k 3.60

More positions owned by BlackRock

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
UnitedHealth (UNH)
Ishares Tr Core S&p500 Etf (IVV)
Exxon Mobil Corporation (XOM)

View all positions for BlackRock

Top funds holding Carmell Therapeutics Corp - US

Hubbell Strickland Wealth Management
Vanguard Group
Carnegie Mellon University
Geode Capital Management
BlackRock
Northern Trust
Warberg Asset Management
OZ Management
BlackRock
Bangor Savings Bank
Commonwealth Equity Services
St. Denis J. Villere & Co
Tower Research Capital
Morgan Stanley
Bank of America Corporation

View all funds holding Carmell Therapeutics Corp - US